Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences Licenses Proteomics Technology from Stanford

NEW YORK, Dec. 17 - BD Biosciences today said it has licensed certain proteomics technology from Stanford University.

 

BD it will use the technology, which is awaiting patent protection, in its flow-cytometry research in order to create new assays and study cellular pathways, the company said.

The technology was developed by Stanford researchers Garry Nolan and Omar Perez.

 

No further information was provided.

The Scan

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.